JP2015520224A5 - - Google Patents

Download PDF

Info

Publication number
JP2015520224A5
JP2015520224A5 JP2015517912A JP2015517912A JP2015520224A5 JP 2015520224 A5 JP2015520224 A5 JP 2015520224A5 JP 2015517912 A JP2015517912 A JP 2015517912A JP 2015517912 A JP2015517912 A JP 2015517912A JP 2015520224 A5 JP2015520224 A5 JP 2015520224A5
Authority
JP
Japan
Prior art keywords
carboxylic acid
phenyl
piperidine
piperidin
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015517912A
Other languages
English (en)
Japanese (ja)
Other versions
JP6182602B2 (ja
JP2015520224A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/055095 external-priority patent/WO2013190508A2/en
Publication of JP2015520224A publication Critical patent/JP2015520224A/ja
Publication of JP2015520224A5 publication Critical patent/JP2015520224A5/ja
Application granted granted Critical
Publication of JP6182602B2 publication Critical patent/JP6182602B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015517912A 2012-06-22 2013-06-21 1−[m−カルボキサミド(ヘテロ)アリール−メチル]−ヘテロシクリル−カルボキサミド誘導体 Expired - Fee Related JP6182602B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12173227.5 2012-06-22
EP12173227 2012-06-22
PCT/IB2013/055095 WO2013190508A2 (en) 2012-06-22 2013-06-21 1-[m-carboxamido(hetero)aryl-methyl]-heterocyclyl-carboxamide derivatives

Publications (3)

Publication Number Publication Date
JP2015520224A JP2015520224A (ja) 2015-07-16
JP2015520224A5 true JP2015520224A5 (enExample) 2016-08-04
JP6182602B2 JP6182602B2 (ja) 2017-08-16

Family

ID=49117908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517912A Expired - Fee Related JP6182602B2 (ja) 2012-06-22 2013-06-21 1−[m−カルボキサミド(ヘテロ)アリール−メチル]−ヘテロシクリル−カルボキサミド誘導体

Country Status (14)

Country Link
US (2) US9428456B2 (enExample)
EP (1) EP2864315B1 (enExample)
JP (1) JP6182602B2 (enExample)
KR (1) KR102101047B1 (enExample)
CN (1) CN104395302A (enExample)
AR (1) AR091516A1 (enExample)
AU (1) AU2013278873B2 (enExample)
BR (1) BR112014031755A8 (enExample)
CA (1) CA2875389C (enExample)
ES (1) ES2768399T3 (enExample)
MX (1) MX364610B (enExample)
RU (1) RU2644761C2 (enExample)
TW (1) TWI623522B (enExample)
WO (1) WO2013190508A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
MA38679B1 (fr) * 2013-05-30 2019-12-31 Idorsia Pharmaceuticals Ltd Modulateurs du récepteur de cxcr7
UA118034C2 (uk) * 2013-11-14 2018-11-12 Елі Ліллі Енд Компані Заміщений піперидилетилпіримідин як інгібітор грелін-o-ацилтрансферази
JP6582056B2 (ja) 2014-12-01 2019-09-25 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd Cxcr7受容体調節剤
MA45782B1 (fr) * 2016-07-28 2021-12-31 Idorsia Pharmaceuticals Ltd Modulateurs du récepteur de cxcr7 pipéridine
WO2018165718A1 (en) 2017-03-17 2018-09-20 Cardio Therapeutics Pty Ltd Heterocyclic inhibitors of pcsk9
WO2019145460A1 (en) 2018-01-26 2019-08-01 Idorsia Pharmaceuticals Ltd Crystalline forms of the cxcr7 receptor antagonist (3s,4s)-1-cyclopropylmethyl-4-{[5-(2,4-difluoro-phenyl)-isoxazole-3-carbonyl]-amino}-piperidine-3-carboxylic acid (1-pyrimidin-2-yl-cyclopropyl)-amide
RU2677268C9 (ru) * 2018-06-15 2019-07-23 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар", (ООО "НИИ ХимРар") Частичный агонист допаминовых D2/D3 рецепторов - метиламид 4-{ 2-[4-(2,3-дихлорфенил)-пиперазин-1-ил]-этил} -пиперидин-1-карбоновой кислоты, способы его получения (варианты) и применения
CN116969941A (zh) * 2022-04-29 2023-10-31 清华大学 PLpro蛋白抑制剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1233818A (en) 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
MXPA05012196A (es) 2003-05-12 2006-02-08 Pfizer Prod Inc Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos.
ES2522579T3 (es) * 2004-06-17 2014-11-17 Cytokinetics, Inc. Compuestos, composiciones y métodos
CN101065374A (zh) * 2004-09-28 2007-10-31 詹森药业有限公司 取代的二哌啶化学引诱物细胞因子受体2拮抗剂
AR063275A1 (es) * 2006-10-12 2009-01-14 Epix Delaware Inc Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2.
WO2009076404A1 (en) * 2007-12-10 2009-06-18 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
CA2742515C (en) * 2008-11-04 2017-07-11 Chemocentryx, Inc. 1,4-diazepane modulators of cxcr7
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
MA38679B1 (fr) 2013-05-30 2019-12-31 Idorsia Pharmaceuticals Ltd Modulateurs du récepteur de cxcr7

Similar Documents

Publication Publication Date Title
JP2015520224A5 (enExample)
RU2015101751A (ru) Производные 1-[м-карбоксамидо(гетеро)арил-метил]-гетероциклил-карбоксамида
FI3743406T3 (fi) Tmem16a-modulaattoreita
CA2542279A1 (en) Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
JP5016494B2 (ja) 5−ht2aセロトニン受容体媒介障害の処置に有用な5−ht2aセロトニン受容体のモジュレーターとしての3−フェニル−ピラゾール誘導体の使用
JP2010504342A5 (enExample)
JP5947307B2 (ja) Kcnq2/3調節因子としての置換6−アミノ−ニコチンアミド
RU2008112221A (ru) Соединения ряда изоиндолимидов, их композиции и способы применения
RU2012152639A (ru) Пиколинамидные и пиримидин-4-карбоксамидные соединения, способ их получения и фармацевтическая композиция, включающая их
HRP20160537T1 (hr) Modulatori indolamina 2,3-dioksigenaze i metode za upotrebu istih
JPWO2013108754A1 (ja) ピラジンカルボキサミド化合物
JP2021512143A5 (enExample)
JP2007519754A5 (enExample)
JP2005518447A5 (enExample)
JP2008509910A5 (enExample)
CN102686563A (zh) 取代的苯甲酰胺衍生物
JP2002525358A5 (enExample)
CA2473892A1 (en) Novel quinoline derivatives
JP2008500336A5 (enExample)
CA2444395A1 (en) Use of nk-1 receptor antagonists against benign prostatic hyperplasia
CA2562130A1 (en) 2-propene-1-ones as hsp 70 inducers
JP2007506703A5 (enExample)
JP2016514709A5 (enExample)
RU2014102432A (ru) Аминометилхинолоны